AnSong Medical Completes Nearly RMB 150 Million Series C3 Financing to Advance High-Performance Medical Ceramics and Innovate Orthopedic Implants

VCBeat learned that recently,Arthrone Co., Ltd. (hereinafter referred to as "Arthrone") has completed a new round of financing of nearly 150 million yuan. This round of financing was jointly completed by Beijing E-town International Investment&Development, Galaxy Capital Management Company Limited, and existing shareholders Beijing E-town Sun Fund Management Co., Ltd. and Med-Fine Capital., the diversified lineup of investors fully demonstrates the capital market's high recognition of Arthrone's technical strength and market prospects in the field of high-end medical device materials.

It is reported that the funds from this round of financing will be mainly used for the following aspects:

Arthrone, as a national high-tech enterprise with advanced ceramic materials technology at its core, isThe only orthopedic medical device manufacturer in China that has simultaneously obtained the registration certificates for zirconia ceramic femoral heads (a nationally innovative medical device) and alumina ceramic femoral heads.Manufacturing enterprises have more than 4 years of clinical follow-up data for their ceramic products, and the current breakage rate is 0%; at the same time, the company's products have also successfully entered the international market, demonstrating strong international competitiveness.

With the acceleration of global aging and the continuous upgrading of medical needs, zirconia ceramics, which possess excellent biocompatibility and mechanical properties, have an extremely broad application prospect in the medical field. Arthrone Co., Ltd., with its uniqueness and first-mover advantage in the domestic zirconia ceramic femoral head sector, has established solid technical and market barriers.

In the future, Arthrone will rely on the Ministry of Industry and Information Technology's "Challenge Leader" platform to focus on overcoming core technologies in the field of biomaterials for medical use, leading the continuous upgrading of the industrial chain.

For this round of investment,Le Wei, General Manager of the Biotechnology Investment Division of Beijing E-town International Investment&Development Co., Ltd."Arthrone's breakthrough in core materials for high-end medical devices is a typical case of solving key technical bottlenecks and achieving import substitution, possessing significant industrial strategic value. At the same time, Arthrone is also a hard technology benchmark enterprise cultivated by the Economic Development Zone, and its development aligns deeply with the zone’s strategy to create a high-end industry hub. This round of investment will facilitate the integration and upgrading of local high-end manufacturing and the biopharmaceutical industry chain."

Arthrone Co., Ltd. Chairman Zhang Jifeng"This round of financing is an important boost for the company's development. The company will continue to focus on the research, development, and innovation of high-performance medical ceramic materials, consolidate and expand its leading position in the orthopedic implant field, and strive to become a globally trusted provider of medical ceramic material solutions. It aims to contribute to enhancing the domestic production level and global competitiveness of high-end medical devices."